{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:42:59Z","timestamp":1788003779562,"version":"build-2784847793"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004006","name":"Bilimsel Ara\u015ftirma Projeleri Birimi, Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["39283"],"award-info":[{"award-number":["39283"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04455-7","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T09:25:07Z","timestamp":1753176307000},"page":"903-922","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dual-targeted protein-coated PLGA nanoparticles for pancreatic cancer therapy: a novel approach using esculetin and curcumin"],"prefix":"10.1007","volume":"399","author":[{"given":"Ayse","family":"Karatug Kacar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Sak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse Nur","family":"Nurdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Ergin K\u0131z\u0131lcay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Bahadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"3","key":"4455_CR1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","volume":"63","author":"S Acharya","year":"2011","unstructured":"Acharya S, Sahoo SK (2011) PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 63(3):170\u2013183","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\/A","key":"4455_CR2","first-page":"363","volume":"23","author":"BB Aggarwal","year":"2003","unstructured":"Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23(1\/A):363\u2013398","journal-title":"Anticancer Res"},{"key":"4455_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-016-0550-2","volume":"15","author":"R Arora","year":"2016","unstructured":"Arora R, Sawney S, Saini V, Steffi C, Tiwari M, Saluja D (2016) Esculetin induces antiproliferative and apoptotic response in pancreatic cancer cells by directly binding to KEAP1. Mol Cancer 15:1\u201315","journal-title":"Mol Cancer"},{"key":"4455_CR4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.biopha.2018.03.101","volume":"102","author":"G Arya","year":"2018","unstructured":"Arya G, Das M, Sahoo SK (2018) Evaluation of curcumin loaded chitosan\/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer. Biomed Pharmacother 102:555\u2013566","journal-title":"Biomed Pharmacother"},{"issue":"13","key":"4455_CR5","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ad15b9","volume":"35","author":"QS Atwan","year":"2024","unstructured":"Atwan QS, Al-Ogaidi I (2024) Improving the targeted delivery of curcumin to esophageal cancer cells via a novel formulation of biodegradable lecithin\/chitosan nanoparticles with downregulated miR-20a and miR-21 expression. Nanotechnology 35(13):135103","journal-title":"Nanotechnology"},{"key":"4455_CR6","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1208\/s12249-014-0146-3","volume":"15","author":"F Bahadori","year":"2014","unstructured":"Bahadori F, Top\u00e7u G, Ero\u011flu MS, \u00d6ny\u00fcksel H (2014) A new lipid-based nano formulation of vinorelbine. AAPS PharmSciTech 15:1138\u20131148","journal-title":"AAPS PharmSciTech"},{"key":"4455_CR7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105037","volume":"138","author":"F Bahadori","year":"2019","unstructured":"Bahadori F, Eskandari Z, Ebrahimi N, Bostan MS, Ero\u011flu MS, Oner ET (2019) Development and optimization of a novel PLGA-Levan based drug delivery system for curcumin, using a quality-by-design approach. Eur J Pharm Sci 138:105037","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"4455_CR8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/10837450.2023.2264964","volume":"28","author":"FB Bal\u0131bey","year":"2023","unstructured":"Bal\u0131bey FB, Bahadori F, Ergin Kizilcay G, Tekin A, Kanimdan E, Kocyigit A (2023) Optimization of PLGA-DSPE hybrid nano-micelles with enhanced hydrophobic capacity for curcumin delivery. Pharm Dev Technol 28(9):843\u2013855","journal-title":"Pharm Dev Technol"},{"issue":"3","key":"4455_CR9","volume":"20","author":"Q Bao","year":"2025","unstructured":"Bao Q, Wang Z, Yang T, Su X, Chen Y, Liu L, Deng Q, Liu Q, Shao C, Zhu W (2025) Curcumin induces mitochondrial dysfunction-associated oxidative DNA damage in ovarian cancer cells. PLoS ONE 20(3):e0319846","journal-title":"PLoS ONE"},{"key":"4455_CR10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123599","volume":"649","author":"C Behera","year":"2024","unstructured":"Behera C, Sandha KK, Banjare N, Shukla MK, Ali SM, Singh M et al (2024) Biodegradable nanocarrier of gemcitabine and tocopherol succinate synergistically ameliorates anti-proliferative response in MIA PaCa-2 cells. Int J Pharm 649:123599","journal-title":"Int J Pharm"},{"issue":"8","key":"4455_CR11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00204-008-0313-y","volume":"82","author":"D Beyersmann","year":"2008","unstructured":"Beyersmann D, Hartwig A (2008) Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch Toxicol 82(8):493\u2013512","journal-title":"Arch Toxicol"},{"key":"4455_CR12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10495-016-1241-6","volume":"21","author":"SS Bhat","year":"2016","unstructured":"Bhat SS, Parray AA, Mushtaq U, Fazili KM, Khanday FA (2016) Actin depolymerization mediated loss of SNTA1 phosphorylation and Rac1 activity has implications on ROS production, cell migration and apoptosis. Apoptosis 21:737\u2013748","journal-title":"Apoptosis"},{"issue":"2","key":"4455_CR13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1152\/physrev.00040.2012","volume":"94","author":"A Bhattacharyya","year":"2014","unstructured":"Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE (2014) Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev 94(2):329\u2013354","journal-title":"Physiol Rev"},{"key":"4455_CR14","volume":"1","author":"S Bimonte","year":"2013","unstructured":"Bimonte S, Barbieri A, Palma G, Luciano A, Rea D (2013) Arra C (2013) Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer. Biomed Res Int 1:810423","journal-title":"Biomed Res Int"},{"key":"4455_CR15","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1016\/j.semcancer.2015.09.007","volume":"35","author":"KI Block","year":"2015","unstructured":"Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin AR, Amin A et al (2015) Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol 35:S276\u2013S304","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"4455_CR16","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/10837450.2020.1745232","volume":"25","author":"S Ceylan","year":"2020","unstructured":"Ceylan S, Bahadori F, Akbas F (2020) Engineering of siRNA loaded PLGA Nano-Particles for highly efficient silencing of GPR87 gene as a target for pancreatic cancer treatment. Pharm Dev Technol 25(7):855\u2013864","journal-title":"Pharm Dev Technol"},{"issue":"5","key":"4455_CR17","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1021\/acsbiomaterials.9b01108","volume":"6","author":"K Chitphet","year":"2019","unstructured":"Chitphet K, Geary SM, Chan CH, Simons AL, Weiner GJ, Salem AK (2019) Combining doxorubicin-loaded pegylated poly (lactide-co-glycolide) nanoparticles with checkpoint inhibition safely enhances therapeutic efficacy in a melanoma model. ACS Biomater Sci Eng 6(5):2659\u20132667","journal-title":"ACS Biomater Sci Eng"},{"issue":"1","key":"4455_CR18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3892\/ijo.2014.2700","volume":"46","author":"JH Cho","year":"2015","unstructured":"Cho JH, Shin JC, Cho JJ, Choi YH, Shim JH, Chae JI (2015) Esculetin (6, 7-dihydroxycoumarin): a potential cancer chemopreventive agent through suppression of Sp1 in oral squamous cancer cells. Int J Oncol 46(1):265\u2013271","journal-title":"Int J Oncol"},{"issue":"18","key":"4455_CR19","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2217\/nnm-2016-0194","volume":"11","author":"BA Cisterna","year":"2016","unstructured":"Cisterna BA, Kamaly N, Choi WI, Tavakkoli A, Farokhzad OC, Vilos C (2016) Targeted nanoparticles for colorectal cancer. Nanomedicine 11(18):2443\u20132456","journal-title":"Nanomedicine"},{"issue":"1","key":"4455_CR20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2008.02.029","volume":"266","author":"JS Clerkin","year":"2008","unstructured":"Clerkin JS, Naughton R, Quiney C, Cotter TG (2008) Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Lett 266(1):30\u201336","journal-title":"Cancer Lett"},{"key":"4455_CR21","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jconrel.2020.09.012","volume":"327","author":"P Dash","year":"2020","unstructured":"Dash P, Piras AM, Dash M (2020) Cell membrane coated nanocarriers-an efficient biomimetic platform for targeted therapy. J Control Release 327:546\u2013570","journal-title":"J Control Release"},{"issue":"1","key":"4455_CR22","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1038\/s41467-020-18745-6","volume":"11","author":"H Deng","year":"2020","unstructured":"Deng H, Yang W, Zhou Z, Tian R, Lin L, Ma Y et al (2020) Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death. Nat Commun 11(1):4951","journal-title":"Nat Commun"},{"key":"4455_CR23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijbiomac.2021.08.115","volume":"189","author":"Z Eskandari","year":"2021","unstructured":"Eskandari Z, Bahadori F, Yenigun VB, Demiray M, Ero\u011flu MS, Kocyigit A, Oner ET (2021) Levan enhanced the NF-\u03baB suppression activity of an oral nano PLGA-curcumin formulation in breast cancer treatment. Int J Biol Macromol 189:223\u2013231","journal-title":"Int J Biol Macromol"},{"key":"4455_CR24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.biomaterials.2017.02.041","volume":"128","author":"RH Fang","year":"2017","unstructured":"Fang RH, Jiang Y, Fang JC, Zhang L (2017) Cell membrane-derived nanomaterials for biomedical applications. Biomaterials 128:69\u201383","journal-title":"Biomaterials"},{"issue":"5","key":"4455_CR25","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1002\/jcp.26242","volume":"233","author":"S Gezginci-Oktayoglu","year":"2018","unstructured":"Gezginci-Oktayoglu S, Onay-Ucar E, Sancar-Bas S, Karatug-Kacar A, Arda ES, Bolkent S (2018) Involvement of dying beta cell originated messenger molecules in differentiation of pancreatic mesenchymal stem cells under glucotoxic and glucolipotoxic conditions. J Cell Physiol 233(5):4235\u20134244","journal-title":"J Cell Physiol"},{"issue":"34","key":"4455_CR26","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.2174\/138161206779010549","volume":"12","author":"GI Giles","year":"2006","unstructured":"Giles GI (2006) The redox regulation of thiol dependent signaling pathways in cancer. Curr Pharm des 12(34):4427\u20134443","journal-title":"Curr Pharm des"},{"issue":"12","key":"4455_CR27","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discovery 12(12):931\u2013947","journal-title":"Nat Rev Drug Discovery"},{"issue":"5","key":"4455_CR28","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1021\/nn301148e","volume":"6","author":"N Graf","year":"2012","unstructured":"Graf N, Bielenberg DR, Kolishetti N, Muus C, Banyard J, Farokhzad OC et al (2012) \u03b1V\u03b23 integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt (IV) prodrug. ACS Nano 6(5):4530\u20134539","journal-title":"ACS Nano"},{"key":"4455_CR29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2015.12.055","volume":"231","author":"MK Gurka","year":"2016","unstructured":"Gurka MK, Pender D, Chuong P, Fouts BL, Sobelov A, McNally MW et al (2016) Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography. J Control Release 231:60\u201367","journal-title":"J Control Release"},{"issue":"11","key":"4455_CR30","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1080\/17425247.2020.1813714","volume":"17","author":"Y Haggag","year":"2020","unstructured":"Haggag Y, Abu Ras B, El-Tanani Y, Tambuwala MM, McCarron P, Isreb M, El-Tanani M (2020) Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells. Expert Opin Drug Deliv 17(11):1655\u20131669","journal-title":"Expert Opin Drug Deliv"},{"issue":"5","key":"4455_CR31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"issue":"9","key":"4455_CR32","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1080\/01635581.2022.2071451","volume":"74","author":"Q Huang","year":"2022","unstructured":"Huang Q, Zhang Y, Zheng Y, Yang H, Yang Y, Mo Y et al (2022) Molecular mechanism of curcumin and its analogs as multifunctional compounds against pancreatic cancer. Nutr Cancer 74(9):3096\u20133108","journal-title":"Nutr Cancer"},{"issue":"12","key":"4455_CR33","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3390\/md21120600","volume":"21","author":"Y Huang","year":"2023","unstructured":"Huang Y, Yan H, Zhang B, Zhu G, Yu J, Xiao X et al (2023) Ascomylactam C induces an immunogenic cell death signature via mitochondria-associated ER stress in lung cancer and melanoma. Mar Drugs 21(12):600","journal-title":"Mar Drugs"},{"key":"4455_CR34","doi-asserted-by":"crossref","unstructured":"Huang X, Zhang W (2024) Macrophage membrane-camouflaged biomimetic nanovesicles for targeted treatment of arthritis. Ageing Research Reviews 102241","DOI":"10.1016\/j.arr.2024.102241"},{"issue":"6","key":"4455_CR35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2217\/nnm-2021-0423","volume":"17","author":"B Ibrahim","year":"2022","unstructured":"Ibrahim B, Mady OY, Tambuwala MM, Haggag YA (2022) pH-sensitive nanoparticles containing 5-fluorouracil and leucovorin as an improved anti-cancer option for colon cancer. Nanomedicine (Lond) 17(6):367\u2013381","journal-title":"Nanomedicine (Lond)"},{"key":"4455_CR36","doi-asserted-by":"crossref","unstructured":"Ingle AP, Goli\u0144ska P, Yadav A, Razzaghi\u2010Abyaneh M, Patel M, Patel R et al (2020) Nanotechnology: a new era in the revolution of drug delivery, diagnosis, and treatment of diseases.\u00a0Nanobiotechnology in diagnosis, drug delivery, and treatment 1\u201324.","DOI":"10.1002\/9781119671732.ch1"},{"key":"4455_CR37","volume":"348","author":"S Jiang","year":"2025","unstructured":"Jiang S, Bao H (2025) Exploring the mechanism of esculetin extracted from Chroogomphus rutilus in treating liver cancer based on network pharmacology, molecular docking, and in vivo experimental validation. J Ethnopharmacol 348:119837","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"4455_CR38","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/jcb.26367","volume":"119","author":"A Karatug Kacar","year":"2018","unstructured":"Karatug Kacar A, Bolkent S (2018) Necrotic cell death occur via JNK pathway with the activity of transcription factor c-Jun by 4-MC in INS-1 cell line. J Cell Biochem 119(2):2048\u20132060","journal-title":"J Cell Biochem"},{"issue":"4","key":"4455_CR39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/jphp.13228","volume":"72","author":"A Karatug Kacar","year":"2020","unstructured":"Karatug Kacar A, Bahadori F, Kepekci Tekkeli SE, Topcu G, Bolkent S (2020) Investigation of cell death mechanism and activity of esculetin-loaded PLGA nanoparticles on insulinoma cells in vitro. J Pharm Pharmacol 72(4):592\u2013606","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"4455_CR40","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.etap.2015.03.003","volume":"39","author":"AD Kim","year":"2015","unstructured":"Kim AD, Han X, Piao MJ, Hewage SRKM, Hyun CL, Cho SJ et al (2015) Esculetin induces death of human colon cancer cells via the reactive oxygen species-mediated mitochondrial apoptosis pathway. Environ Toxicol Pharmacol 39(2):982\u2013989","journal-title":"Environ Toxicol Pharmacol"},{"issue":"3\u20134","key":"4455_CR41","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bbrc.2017.10.095","volume":"494","author":"SM Kim","year":"2017","unstructured":"Kim SM, Hur DY, Hong SW, Kim JH (2017) EBV-encoded EBNA1 regulates cell viability by modulating miR34a-NOX2-ROS signaling in gastric cancer cells. Biochem Biophys Res Commun 494(3\u20134):550\u2013555","journal-title":"Biochem Biophys Res Commun"},{"key":"4455_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-015-0271-2","volume":"7","author":"J Leibacher","year":"2016","unstructured":"Leibacher J, Henschler R (2016) Biodistribution, migration and homing of systemically applied mesenchymal stem\/stromal cells. Stem Cell Res Ther 7:1\u201312","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"4455_CR43","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/cncr.20605","volume":"101","author":"L Li","year":"2004","unstructured":"Li L, Aggarwal BB, Shishodia S, Abbruzzese J, Kurzrock R (2004) Nuclear factor-\u03baB and I\u03baB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer: Interdiscip Intl J Am Cancer Soc 101(10):2351\u20132362","journal-title":"Cancer: Interdiscip Intl J Am Cancer Soc"},{"key":"4455_CR44","first-page":"1","volume":"6","author":"X Li","year":"2013","unstructured":"Li X, Fang P, Mai J, Choi ET, Wang H, Yang XF (2013) Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol 6:1\u201319","journal-title":"J Hematol Oncol"},{"key":"4455_CR45","volume":"254","author":"M Li","year":"2024","unstructured":"Li M, Liu Y, Liu Y, Lin J, Ding L, Wu S et al (2024) Fabrication of targeted and pH responsive lysozyme-hyaluronan nanoparticles for 5-fluorouracil and curcumin co-delivery in colorectal cancer therapy. Int J Biol Macromol 254:127836","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"4455_CR46","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.7150\/thno.64805","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu L, Kshirsagar PG, Gautam SK, Gulati M, Wafa EI, Christiansen JC et al (2022) Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies. Theranostics 12(3):1030","journal-title":"Theranostics"},{"key":"4455_CR47","volume":"22","author":"X Liu","year":"2023","unstructured":"Liu X, Chu Z, Chen B, Ma Y, Xu L, Qian H et al (2023) Cancer cell membrane-coated upconversion nanoparticles\/ZnxMn1-xS core-shell nanoparticles for targeted photodynamic and chemodynamic therapy of pancreatic cancer. Materials Today Bio 22:100765","journal-title":"Materials Today Bio"},{"issue":"1","key":"4455_CR48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1021\/acsmedchemlett.4c00425","volume":"16","author":"M Liu","year":"2024","unstructured":"Liu M, Sun Y, Wei Q, Zhang A, Wang S, Wang D, Dong Z, Ma X, Yan R, Wang Y (2024) 4T1 cell membrane biomimetic nanovehicle for enhanced breast cancer treatment. ACS Med Chem Lett 16(1):51\u201358","journal-title":"ACS Med Chem Lett"},{"issue":"9","key":"4455_CR49","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.3390\/ijms23094723","volume":"23","author":"LV Loftus","year":"2022","unstructured":"Loftus LV, Amend SR, Pienta KJ (2022) Interplay between cell death and cell proliferation reveals new strategies for cancer therapy. Int J Mol Sci 23(9):4723","journal-title":"Int J Mol Sci"},{"issue":"42","key":"4455_CR50","doi-asserted-by":"crossref","first-page":"20261","DOI":"10.1039\/C9NR07257H","volume":"11","author":"WJ McDaid","year":"2019","unstructured":"McDaid WJ, Greene MK, Johnston MC, Pollheimer E, Smyth P, McLaughlin K et al (2019) Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours. Nanoscale 11(42):20261\u201320273","journal-title":"Nanoscale"},{"issue":"1","key":"4455_CR51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/1541-4337.12047","volume":"13","author":"SF Nabavi","year":"2014","unstructured":"Nabavi SF, Daglia M, Moghaddam AH, Habtemariam S, Nabavi SM (2014) Curcumin and liver disease: from chemistry to medicine. Comprehensive Reviews in Food Science and Food Safety 13(1):62\u201377","journal-title":"Comprehensive Reviews in Food Science and Food Safety"},{"key":"4455_CR52","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.phrs.2015.06.013","volume":"100","author":"IS Okon","year":"2015","unstructured":"Okon IS, Zou MH (2015) Mitochondrial ROS and cancer drug resistance: implications for therapy. Pharmacol Res 100:170\u2013174","journal-title":"Pharmacol Res"},{"issue":"9","key":"4455_CR53","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/jps.20874","volume":"96","author":"T Ozben","year":"2007","unstructured":"Ozben T (2007) Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 96(9):2181\u20132196","journal-title":"J Pharm Sci"},{"key":"4455_CR54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cbi.2015.09.015","volume":"242","author":"H Pan","year":"2015","unstructured":"Pan H, Wang BH, Lv W, Jiang Y, He L (2015) Esculetin induces apoptosis in human gastric cancer cells through a cyclophilin D-mediated mitochondrial permeability transition pore associated with ROS. Chem Biol Interact 242:51\u201360","journal-title":"Chem Biol Interact"},{"issue":"2","key":"4455_CR55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.taap.2007.10.003","volume":"227","author":"C Park","year":"2008","unstructured":"Park C, Jin CY, Kim GY, Choi IW, Kwon TK, Choi BT et al (2008) Induction of apoptosis by esculetin in human leukemia U937 cells through activation of JNK and ERK. Toxicol Appl Pharmacol 227(2):219\u2013228","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"4455_CR56","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G et al (2020) ROS in cancer therapy: the bright side of the moon. Exp Mol Med 52(2):192\u2013203","journal-title":"Exp Mol Med"},{"key":"4455_CR57","first-page":"66","volume":"2","author":"N Rabiee","year":"2018","unstructured":"Rabiee N, Deljoo S, Rabiee M (2018) Curcumin-hybrid nanoparticles in drug delivery system. Asian J Nanosci Mater 2:66\u201391","journal-title":"Asian J Nanosci Mater"},{"key":"4455_CR58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106968","volume":"143","author":"A Rahman","year":"2024","unstructured":"Rahman A, Jain RSK, Meghana P, Nippu BN, Manjunatha KS, Rajaput PS et al (2024) Tetrahydrobenzothiophene derivatives ameliorate MIA PaCa-2 cell progression and induces apoptosis via inhibiting EGFR2 tyrosine kinase signal. Bioorg Chem 143:106968","journal-title":"Bioorg Chem"},{"issue":"13","key":"4455_CR59","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.ejca.2004.02.031","volume":"40","author":"MF Renschler","year":"2004","unstructured":"Renschler MF (2004) The emerging role of reactive oxygen species in cancer therapy. Eur J Cancer 40(13):1934\u20131940","journal-title":"Eur J Cancer"},{"issue":"1","key":"4455_CR60","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","volume":"9","author":"D Rosenblum","year":"2018","unstructured":"Rosenblum D, Joshi N, Tao W, Karp JM, Peer D (2018) Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun 9(1):1410","journal-title":"Nat Commun"},{"key":"4455_CR61","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113631","volume":"233","author":"BN Saren","year":"2024","unstructured":"Saren BN, Mahajan S, Aalhate M, Kumar R, Chatterjee E, Maji I et al (2024) Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer. Colloids Surf, B 233:113631","journal-title":"Colloids Surf, B"},{"key":"4455_CR62","doi-asserted-by":"crossref","first-page":"114786","DOI":"10.1016\/j.colsurfb.2025.114786","volume":"253","author":"L Scorzafave","year":"2025","unstructured":"Scorzafave L, Manti EN, Fiorillo M, Curcio M, Cirillo G, Frattaruolo L, Nicoletta FP, Cappello AR, Iemma F (2025) Merging fusogenic DOPE and a tumour targeted self-assembling biopolymer: smart hybrid liposomes for drug vectorization in cancer therapy. Colloids Surf. B, Biointerf 253:114786","journal-title":"Colloids Surf. B, Biointerf"},{"issue":"2","key":"4455_CR63","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","volume":"48","author":"LA Sena","year":"2012","unstructured":"Sena LA, Chandel NS (2012) Physiological roles of mitochondrial reactive oxygen species. Mol Cell 48(2):158\u2013167","journal-title":"Mol Cell"},{"issue":"3","key":"4455_CR64","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1166\/mex.2014.1160","volume":"4","author":"B Sivakumar","year":"2014","unstructured":"Sivakumar B, Aswathy RG, Nagaoka Y, Iwai S, Hasumura T, Venugopal K et al (2014) Augmented cellular uptake and antiproliferation against pancreatic cancer cells induced by targeted curcumin and SPION encapsulated PLGA nanoformulation. Mater Express 4(3):183\u2013195","journal-title":"Mater Express"},{"issue":"1","key":"4455_CR65","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12951-022-01475-w","volume":"20","author":"W Song","year":"2022","unstructured":"Song W, Jia P, Zhang T, Dou K, Liu L, Ren Y et al (2022) Cell membrane-camouflaged inorganic nanoparticles for cancer therapy. J Nanobiotechnol 20(1):289","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4455_CR66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1196\/annals.1427.015","volume":"1147","author":"AA Starkov","year":"2008","unstructured":"Starkov AA (2008) The role of mitochondria in reactive oxygen species metabolism and signaling. Ann N Y Acad Sci 1147(1):37\u201352","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"4455_CR67","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.molcel.2020.05.014","volume":"78","author":"A Strasser","year":"2020","unstructured":"Strasser A, Vaux DL (2020) Cell death in the origin and treatment of cancer. Mol Cell 78(6):1045\u20131054","journal-title":"Mol Cell"},{"issue":"3","key":"4455_CR68","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1158\/1535-7163.MCT-07-2272","volume":"7","author":"M Sun","year":"2008","unstructured":"Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R (2008) Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7(3):464\u2013473","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"4455_CR69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2008.02.044","volume":"266","author":"M Ushio-Fukai","year":"2008","unstructured":"Ushio-Fukai M, Nakamura Y (2008) Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266(1):37\u201352","journal-title":"Cancer Lett"},{"issue":"2","key":"4455_CR70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3835(02)00031-9","volume":"183","author":"CJ Wang","year":"2002","unstructured":"Wang CJ, Hsieh YJ, Chu CY, Lin YL, Tseng TH (2002) Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin. Cancer Lett 183(2):163\u2013168","journal-title":"Cancer Lett"},{"issue":"6","key":"4455_CR71","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.sjbs.2016.12.001","volume":"25","author":"SQ Wang","year":"2018","unstructured":"Wang SQ, Zhang Q, Sun C, Liu GY (2018) Ifosfamide-loaded lipid-core-nanocapsules to increase the anticancer efficacy in MG63 osteosarcoma cells. Saudi Journal of Biological Sciences 25(6):1140\u20131145","journal-title":"Saudi Journal of Biological Sciences"},{"issue":"4","key":"4455_CR72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00114-025-01988-y","volume":"112","author":"X Wang","year":"2025","unstructured":"Wang X, Chai R, Li J, Chen Y, Li Z, Bian Y, Zhao S (2025) Curcumin protects extracellular matrix to maintain microenvironmental stability inhibiting colon cancer metastasis through HPSE\/IL-6\/STAT5 axis. Naturwissenschaften 112(4):47","journal-title":"Naturwissenschaften"},{"issue":"Pt 1","key":"4455_CR73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/bj3130017","volume":"313","author":"H Wiseman","year":"1996","unstructured":"Wiseman H, Halliwell B (1996) Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochemical Journal 313(Pt 1):17","journal-title":"Biochemical Journal"},{"issue":"5","key":"4455_CR74","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4161\/cbt.6.5.4092","volume":"6","author":"XJ Wu","year":"2007","unstructured":"Wu XJ, Hua X (2007) Targeting ROS: selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound. Cancer Biol Ther 6(5):646\u2013647","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"4455_CR75","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/1759-7714.14773","volume":"14","author":"X Wu","year":"2023","unstructured":"Wu X, Chen H, Liu N, Liu S, Lin G (2023) Curcumin suppresses lung cancer progression via circRUNX1 mediated miR-760\/RAB3D axis. Thoracic Cancer 14(5):506\u2013516","journal-title":"Thoracic Cancer"},{"key":"4455_CR76","volume":"558","author":"Y Wu","year":"2023","unstructured":"Wu Y, Zhu R, Zhou M, Liu J, Dong K, Zhao S et al (2023) Homologous cancer cell membrane-camouflaged nanoparticles target drug delivery and enhance the chemotherapy efficacy of hepatocellular carcinoma. Cancer Lett 558:216106","journal-title":"Cancer Lett"},{"issue":"3","key":"4455_CR77","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s10637-022-01231-9","volume":"40","author":"T Xue","year":"2022","unstructured":"Xue T, Xu P, Padelford J, Xue X, Wu AY, Li Y et al (2022) Actively targeted delivery of SN38 by ultrafine iron oxide nanoparticle for treating pancreatic cancer. Invest New Drugs 40(3):546\u2013555","journal-title":"Invest New Drugs"},{"issue":"1","key":"4455_CR78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcis.2010.05.022","volume":"351","author":"MM Yallapu","year":"2010","unstructured":"Yallapu MM, Gupta BK, Jaggi M, Chauhan SC (2010) Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. Journal of Colloid and \u0130nterface Science 351(1):19\u201329","journal-title":"Journal of Colloid and \u0130nterface Science"},{"issue":"1","key":"4455_CR79","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1038\/s41467-023-42740-2","volume":"14","author":"J Yan","year":"2023","unstructured":"Yan J, Ma X, Liang D, Ran M, Zheng D, Chen X, Zhou S, Sun W, Shen X, Zhang H (2023) An autocatalytic multicomponent DNAzyme nanomachine for tumor-specific photothermal therapy sensitization in pancreatic cancer. Nat Commun 14(1):6905","journal-title":"Nat Commun"},{"key":"4455_CR80","doi-asserted-by":"crossref","unstructured":"Yan, J., Wang, M., Lv, S., Chen, D., Wu, Z., Zhou, D., ... & Wei, Y. (2024). SiATG5-loaded cancer cell membrane-fused liposomes induced increased uptake of albumin-bound chemotherapeutics by pancreatic cancer cells. Journal of Controlled Release, 367, 620\u2013636","DOI":"10.1016\/j.jconrel.2024.01.055"},{"key":"4455_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-017-0664-4","volume":"37","author":"H Yang","year":"2018","unstructured":"Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M et al (2018) The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res 37:1\u201310","journal-title":"J Exp Clin Cancer Res"},{"issue":"27","key":"4455_CR82","doi-asserted-by":"crossref","first-page":"22963","DOI":"10.1021\/acsami.8b05363","volume":"10","author":"N Yang","year":"2018","unstructured":"Yang N, Ding Y, Zhang Y, Wang B, Zhao X, Cheng K et al (2018) Surface functionalization of polymeric nanoparticles with umbilical cord-derived mesenchymal stem cell membrane for tumor-targeted therapy. ACS Appl Mater Interfaces 10(27):22963\u201322973","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"4455_CR83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jpp\/rgac083","volume":"75","author":"W Yin","year":"2023","unstructured":"Yin W, Fu X, Chang W, Han L, Meng J, Cao A, Ren X, Fan Z, Zhou S (2023) Antiovarian cancer mechanism of esculetin: inducing G0\/G1 arrest and apoptosis via JAK2\/STAT3 signalling pathway. J Pharm Pharmacol 75(1):87\u201397","journal-title":"J Pharm Pharmacol"},{"key":"4455_CR84","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.12659\/MSM.916246","volume":"25","author":"G Zhang","year":"2019","unstructured":"Zhang G, Xu Y, Zhou HF (2019) Esculetin inhibits proliferation, invasion, and migration of laryngeal cancer in vitro and in vivo by inhibiting Janus kinas (JAK)-signal transducer and activator of transcription-3 (STAT3) activation. Med Sci Mon: \u0130nt Med J Exp Clin Res 25:7853","journal-title":"Med Sci Mon: \u0130nt Med J Exp Clin Res"},{"key":"4455_CR85","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c10568","author":"C Zhang","year":"2024","unstructured":"Zhang C, Tang S, Wang M, Li L, Li J, Wang D, Mi X, Zhang Y, Tan X, Yue S (2024) \u201cTriple-punch\u201d strategy exosome-mimetic nanovesicles for triple negative breast cancer therapy. ACS Nano. https:\/\/doi.org\/10.1021\/acsnano.3c10568","journal-title":"ACS Nano"},{"issue":"32","key":"4455_CR86","doi-asserted-by":"crossref","first-page":"e2309314","DOI":"10.1002\/advs.202309314","volume":"11","author":"H Zhang","year":"2024","unstructured":"Zhang H, Jiang W, Song T, Song M, Liu S, Zhou J, Cheng H, Ding Y (2024) Lipid-polymer nanoparticles mediate compartmentalized delivery of Cas9 and sgRNA for glioblastoma vasculature and immune reprogramming. Adv Sci 11(32):e2309314","journal-title":"Adv Sci"},{"key":"4455_CR87","volume":"674","author":"J Zhang","year":"2025","unstructured":"Zhang J, Yang Q, Zhang Y, Zhang Q, Wan Y, Yan G, Wang X (2025) Cancer cell membrane-coated sulindac-ortho ester nanoprodrug for inhibiting COX-2 expression and chemo-photothermal synergistic antitumor therapy. Int J Pharm 674:125460","journal-title":"Int J Pharm"},{"key":"4455_CR88","doi-asserted-by":"crossref","unstructured":"Zhang, W., Fan, Y., Zhang, J., Shi, D., Yuan, J., Ashrafizadeh, M., ... & Zhang, X. (2023). Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer. Drug Resistance Updates, 71, 101005","DOI":"10.1016\/j.drup.2023.101005"},{"issue":"4","key":"4455_CR89","doi-asserted-by":"crossref","first-page":"358","DOI":"10.15407\/exp-oncology.2024.04.358","volume":"46","author":"L Zhu","year":"2025","unstructured":"Zhu L, Ahn BC (2025) Natural killer cell-derived exosome mimetics as natural nanocarriers for in vitro delivery of chemotherapeutics to thyroid cancer cells. Exp Oncol 46(4):358\u2013367","journal-title":"Exp Oncol"},{"issue":"9","key":"4455_CR90","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1021\/acs.nanolett.6b02786","volume":"16","author":"JY Zhu","year":"2016","unstructured":"Zhu JY, Zheng DW, Zhang MK, Yu WY, Qiu WX, Hu JJ et al (2016) Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranes. Nano Lett 16(9):5895\u20135901","journal-title":"Nano Lett"},{"issue":"3","key":"4455_CR91","first-page":"128","volume":"54","author":"X Zhu","year":"2018","unstructured":"Zhu X, Gu J, Qian H (2018) Esculetin attenuates the growth of lung cancer by downregulating Wnt targeted genes and suppressing NF-\u03baB. Arch Bronconeumol 54(3):128\u2013133","journal-title":"Arch Bronconeumol"},{"key":"4455_CR92","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1007\/s11033-011-1273-5","volume":"39","author":"H Zong","year":"2012","unstructured":"Zong H, Wang F, Fan QX, Wang LX (2012) Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways. Mol Biol Rep 39:4803\u20134808","journal-title":"Mol Biol Rep"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04455-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04455-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04455-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:09:10Z","timestamp":1771538950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04455-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4455"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04455-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The affiliation of  Dr. Rabia Sak is incorrect. It is now corrected with the correct one.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}